Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
McKinsey
Boehringer Ingelheim
Medtronic
Colorcon

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Jubilant Generics Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for JUBILANT GENERICS, and what generic and branded alternatives to JUBILANT GENERICS drugs are available?

JUBILANT GENERICS has thirty-nine approved drugs.



Summary for Jubilant Generics
US Patents:0
Tradenames:35
Ingredients:34
NDAs:39
Patent Litigation for Jubilant Generics: See patent lawsuits for Jubilant Generics

Drugs and US Patents for Jubilant Generics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Generics MONTELUKAST SODIUM montelukast sodium TABLET, CHEWABLE;ORAL 203795-001 Feb 27, 2015 AB RX No No   Start Trial   Start Trial
Jubilant Generics PAROXETINE HYDROCHLORIDE paroxetine hydrochloride TABLET;ORAL 205528-004 Nov 27, 2015 AB RX No No   Start Trial   Start Trial
Jubilant Generics PAROXETINE HYDROCHLORIDE paroxetine hydrochloride TABLET;ORAL 205528-001 Nov 27, 2015 AB RX No No   Start Trial   Start Trial
Jubilant Generics CELECOXIB celecoxib CAPSULE;ORAL 207061-004 Apr 4, 2017 AB RX No No   Start Trial   Start Trial
Jubilant Generics RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 203334-002 Oct 16, 2015 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Moodys
AstraZeneca
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.